Background Patients with cancer have an increased risk of complications from SARS-CoV-2
infection. Vaccination to prevent COVID-19 is recommended, but data on the …

Patients with cancer are at an increased risk of severe COVID-19. Breakthrough infections
after two vaccinations do occur and can be lethal. 1–3 Most patients treated for a solid …

Introduction Patients with cancer are presumed a frail group at high risk of contracting
coronavirus disease (COVID-19), and vaccination represents a cornerstone in addressing …

Abstract Background Although SARS-CoV-2 vaccines immunogenicity in patients with
cancer has been investigated, whether they can significantly improve the severity of COVID …

Emerging efficacy data have led to the emergency use authorization or approval of COVID-
19 vaccines in several countries worldwide. Most trials of COVID-19 vaccines excluded …

Abstract Coronavirus disease 2019 (COVID-19) has affected more than 96 million people
worldwide, leading the World Health Organization (WHO) to declare a pandemic in March …

Background: Cancer patients show increased morbidity with COVID-19 and need effective
immunization strategies. Many healthcare regulatory agencies recommend administering …

Patients with cancer have a higher risk of severe coronavirus disease (COVID-19) and
associated mortality than the general population. Owing to this increased risk, patients with …

Purpose Patients with cancer have an increased risk of coronavirus disease 2019 (COVID-
19) and an attenuated responses to various vaccines. This meta-analysis aims to assess the …

Background Vaccination is an important preventive health measure to protect against
symptomatic and severe COVID-19. Impaired immunity secondary to an underlying …